CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML

SIMPLE SUMMARY: Secondary AML (s-AML) including therapy-related acute myeloid leukemia (t-AML) and acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) represent approximately one quarter of all AML cases. These AML subcategories are predominantly associated with advanced age and pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Molica, Matteo, Perrone, Salvatore, Mazzone, Carla, Cesini, Laura, Canichella, Martina, de Fabritiis, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221356/
https://www.ncbi.nlm.nih.gov/pubmed/35740508
http://dx.doi.org/10.3390/cancers14122843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221356/
https://www.ncbi.nlm.nih.gov/pubmed/35740508
http://dx.doi.org/10.3390/cancers14122843

Ejemplares similares